FACT shares jump nearly 3% as China lifts fertiliser export curbs to India
Shares of Fertilisers and Chemicals Travancore Ltd (FACT) surged almost 3% on Tuesday, August 19, after reports confirmed that China has lifted restrictions on fertiliser exports to India, a move that is expected to ease supply concerns for the agriculture sector.
At 10:46 am, FACT shares were trading at ₹991.85 apiece, up 2.81% (₹27.10) from the previous close of ₹964.75. The stock hit an intraday high of ₹998, with a market capitalisation of ₹641.44 billion.
According to ET, the breakthrough came after External Affairs Minister S. Jaishankar met his Chinese counterpart Wang Yi last month. India had strongly raised concerns over China's sudden export curbs on fertilisers, which had directly impacted the availability of Di-Ammonium Phosphate (DAP) during the crucial Rabi season.
Sources said Beijing has now not only eased fertiliser export restrictions, but also conveyed its readiness to allow shipments of rare earth magnets, minerals and tunnel boring machines to India — three key requests New Delhi had flagged in talks. Reports indicate that shipments have already begun.
The decision comes at a crucial time for India's fertiliser industry, which has been grappling with high input costs and tight supply. Analysts believe easing of Chinese export restrictions will help stabilise domestic prices and improve availability, directly benefiting fertiliser producers such as FACT.
The development also carries significant geopolitical weight, as it signals gradual normalisation of trade ties between India and China, following troop disengagement along the Line of Actual Control.
FACT shares have already gained sharply over the past year, rising from a 52-week low of ₹565 to a high of ₹1,112. With fertiliser supply outlook improving, market watchers expect the stock to remain in focus in the near term.
Disclaimer: This article is for informational purposes only and should not be construed as investment advice.
Ahmedabad Plane Crash
Aditya Bhagchandani serves as the Senior Editor and Writer at Business Upturn, where he leads coverage across the Business, Finance, Corporate, and Stock Market segments. With a keen eye for detail and a commitment to journalistic integrity, he not only contributes insightful articles but also oversees editorial direction for the reporting team.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Upturn
22 minutes ago
- Business Upturn
Lupin launches Bosentan Tablets for Oral Suspension in US with 180-day exclusivity
By Aditya Bhagchandani Published on August 20, 2025, 10:16 IST Shares of Lupin Ltd. will be in focus on Wednesday, August 20, after the company announced the launch of Bosentan Tablets for Oral Suspension, 32 mg, in the United States. The launch, made in partnership with NATCO Pharma, comes with the advantage of 180-day first-to-file generic exclusivity, a significant opportunity in the niche space of pulmonary arterial hypertension (PAH) treatment. The government filing confirmed that Lupin's alliance partner NATCO Pharma received U.S. FDA approval for its Abbreviated New Drug Application (ANDA). Bosentan is indicated for the treatment of PAH in pediatric patients aged three years and above with idiopathic or congenital PAH, aiming to improve pulmonary vascular resistance and exercise ability. The drug is bioequivalent to Actelion Pharmaceuticals' Tracleer® Tablets for Oral Suspension, which had estimated annual U.S. sales of around USD 10 million as of June 2025. Lupin, a major player in generics and specialty formulations, continues to strengthen its U.S. portfolio with this launch. The company has a strong footprint across therapy areas, including respiratory, cardiovascular, anti-diabetic, and women's health, and operates 15 manufacturing sites and seven research centers globally. With the exclusivity window, Lupin and NATCO are positioned to capture market share in the PAH treatment segment before competition intensifies. Disclaimer: This article is for informational purposes only and should not be considered investment advice. Please consult a financial advisor before making any investment decisions. Ahmedabad Plane Crash Aditya Bhagchandani serves as the Senior Editor and Writer at Business Upturn, where he leads coverage across the Business, Finance, Corporate, and Stock Market segments. With a keen eye for detail and a commitment to journalistic integrity, he not only contributes insightful articles but also oversees editorial direction for the reporting team.
Business Upturn
22 minutes ago
- Business Upturn
PG Electroplast shares in focus after partnership with PAX India for POS device manufacturing
By Aditya Bhagchandani Published on August 20, 2025, 10:23 IST Shares of PG Electroplast Ltd. were in focus on Wednesday, August 20, after the company announced a strategic manufacturing partnership with PAX India, a subsidiary of Hong Kong–listed PAX Global Technology Limited. As per the agreement, PG Electroplast will manufacture PAX-branded Point-of-Sale (POS) devices at its existing facilities in India, with production expected to begin by the end of this year. This marks PG Electroplast's entry into the financial technology hardware segment, expanding its portfolio beyond consumer durables into high-growth digital infrastructure solutions. Commenting on the deal, Vikas Gupta, Managing Director – Operations, PG Electroplast, said the collaboration strengthens the company's role under the Make in India initiative, making it one of the few Indian manufacturers of POS devices. PAX India's CEO, Sanjeev Sandhu, highlighted that local manufacturing would enhance reliability, efficiency, and scalability for Indian customers. The move is seen as a significant diversification step for PG Electroplast, which already supplies contract manufacturing services for air-conditioners, washing machines, LED TVs, and other consumer durables. Analysts note that the entry into payments infrastructure could open up new growth opportunities as India's digital payments market continues to expand rapidly. Disclaimer: This article is for informational purposes only and not a recommendation to buy or sell any stock. Ahmedabad Plane Crash Aditya Bhagchandani serves as the Senior Editor and Writer at Business Upturn, where he leads coverage across the Business, Finance, Corporate, and Stock Market segments. With a keen eye for detail and a commitment to journalistic integrity, he not only contributes insightful articles but also oversees editorial direction for the reporting team.
Business Upturn
37 minutes ago
- Business Upturn
Rane Holdings shares rise nearly 3% after Rs 50 crore investment in subsidiary
By Aditya Bhagchandani Published on August 20, 2025, 09:32 IST Shares of Rane Holdings Ltd. gained close to 3% on Wednesday, August 20, trading at ₹1,514.45 on the BSE, after the company announced a fresh investment in its wholly owned subsidiary, Rane Steering Systems Private Limited (RSSL). In a regulatory filing, Rane Holdings informed that RSSL allotted 20,00,000 equity shares of ₹10 each on a rights basis, fully subscribed by the parent. The investment, valued at ₹50 crore, was made at an issue price of ₹250 per share (including a premium of ₹240). Despite the fresh infusion, Rane Holdings' shareholding in RSSL remains unchanged at 100%. The company clarified that the transaction was carried out at arm's length, with pricing based on a registered valuer's report. Why the investment? According to the filing, the proceeds will be used by RSSL to meet operational and capital expenditure requirements and to pursue further growth opportunities. RSSL, incorporated in 1995, manufactures steering columns and reported a turnover of ₹1,706.33 crore in FY25. Over the past three years, it has shown steady growth with turnover of ₹1,510.34 crore in FY23 and ₹1,718.73 crore in FY24. Market reaction The announcement boosted investor sentiment, with shares climbing nearly 3% in early trade. Analysts say the fresh capital infusion strengthens RSSL's balance sheet and positions it well for expansion in the auto component sector. Ahmedabad Plane Crash Aditya Bhagchandani serves as the Senior Editor and Writer at Business Upturn, where he leads coverage across the Business, Finance, Corporate, and Stock Market segments. With a keen eye for detail and a commitment to journalistic integrity, he not only contributes insightful articles but also oversees editorial direction for the reporting team.
